Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma

Human Pathology

Volumn 43, Issue 9, 2012, Pages 1405-1412

  Zhang, Jing ^a,b   Chang, Doo Young ^a   Mercado Uribe, Imelda ^a   Liu, Jinsong ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Immunohistochemistry; Ovarian carcinoma; Prognosis; Sex determining region Y box 2 (SOX2)

Indexed keywords

CISPLATIN; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER STEM CELL; CANCER SURVIVAL; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; EMBRYONIC STEM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MIXED MULLERIAN TUMOR; OVARY CARCINOMA; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEMINOMA; TISSUE MICROARRAY; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR RECURRENCE; UTERINE TUBE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SOXB1 TRANSCRIPTION FACTORS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84864280124     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.10.016     Document Type: Article

References (34)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111 (Pubitemid 33041634)
3. S.J. Akunuru, J. Palumbo, Q.J. Zhai, and Y. Zheng Rac1 targeting suppresses human non-small cell lung adenocarcinoma cancer stem cell activity PLoS One 6 2011 e16951
4. P. Scaffidi, and M.E. Bianchi Spatially precise DNA bending is an essential activity of the sox2 transcription factor J Biol Chem 276 2001 47296 47302
5. H. Fong, K.A. Hohenstein, and P.J. Donovan Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells Stem Cells 26 2008 1931 1938
6. K. Takahashi, K. Tanabe, and M. Ohnuki Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872 (Pubitemid 350138099)
7. L.J. Chew, and V. Gallo The yin and yang of Sox proteins: activation and repression in development and disease J Neurosci Res 87 2009 3277 3287
8. A.C. Laga, Q. Zhan, C. Weishaupt, J. Ma, M.H. Frank, and G.F. Murphy SOX2 and nestin expression in human melanoma: an immunohistochemical and experimental study Exp Dermatol 20 2011 339 345
9. L. Annovazzi, M. Mellai, V. Caldera, G. Valente, and D. Schiffer SOX2 expression and amplification in gliomas and glioma cell lines Cancer Genomics Proteomics 8 2011 139 147
10. T. Otsubo, Y. Akiyama, K. Yanaqihara, and Y. Yuasa SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis Br J Cancer 98 2008 824 831 (Pubitemid 351272602)
11. S. Saigusa, K. Tanaka, and Y. Toiyama Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy Ann Surg Oncol 16 2009 3488 3498
12. Y. Chen, L. Shi, and L. Zhang The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer J Biol Chem 283 2008 17969 17978
13. P. Huang, J. Qiu, and B. Li Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy Clin Biochem 44 2011 582 589
14. Y. Sanada, K. Yoshida, M. Ohara, M. Oeda, K. Konishi, and Y. Tsutani Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components Pancreas 32 2006 164 170
15. X. Jia, X. Li, and Y. Xu SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell J Mol Cell Biol 2011
16. T. Hussenet, and S. du Manoir SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis Cell Cycle 9 2010 1480 1486
17. M. Bani-Yaghoub, R.G. Tremblay, and J.X. Lei Role of Sox2 in the development of the mouse neocortex Dev Biol 295 2006 52 66 (Pubitemid 44041325)
18. F.A. Tavassoeli, and P. Devilee Pathology and genetics of tumours of the breast and female genital organs 2003 Lyon IARC Press 117 145
19. P. Russell The pathological assessment of ovarian neoplasms. I: introduction to the common epithelial tumours and analysis of benign epithelial tumours Pathology 11 1979 5 26 (Pubitemid 9133909)
20. P. Russell The pathological assessment of ovarian neoplasms. II: the proliferating epithelial tumours Pathology 11 1979 251 282 (Pubitemid 9229175)
21. P. Russell The pathological assessment of ovarian neoplasms. III: the malignant epithelial tumours Pathology 11 1979 493 532 (Pubitemid 10248519)
22. A. Malpica, M.T. Deavers, and K. Lu Grading ovarian serous carcinoma using a two-tier system Am J Surg Pathol 28 2004 496 504 (Pubitemid 38436523)
23. J.H. Shepherd Revised FIGO staging for gynaecological cancer Br J Obstet Gynaecol 96 1989 889 892
24. G.J. Rustin, A.E. Nelstrop, and M. Crawford Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125 J Clin Oncol 15 1997 172 176 (Pubitemid 27020570)
25. G.J. Rustin, A.E. Nelstrop, M.K. Tuxen, and H.E. Lambert Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study Ann Oncol 7 1996 361 364 (Pubitemid 26246787)
26. B. Chang, G. Liu, and F. Xue ALDH1 expression correlates with favorable prognosis in ovarian cancers Mod Pathol 22 2009 817 823
27. D.G. Rosen, G. Yang, and M.T. Deavers Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma Cancer 106 2006 1925 1932 (Pubitemid 43673207)
28. Q. Wang, W. He, and C. Lu Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma Anticancer Res 29 2009 1233 1241
29. T. Hussenet, S. Dali, and J. Exinger SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas PLoS One 5 2010 e8960
30. X. Zhang, H. Yu, and R. Zhu SOX2 in gastric carcinoma, but not Hath1, is related to patients' clinicopathological features and prognosis J Gastrointest Surg 14 2010 1220 1226
31. T. Wilbertz, P. Wagner, and K. Petersen SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer Mod Pathol 24 2011 944 953
32. P.A. Zuk The intracellular distribution of the ES cell totipotent markers OCT4 and Sox2 in adult stem cells differs dramatically according to commercial antibody used J Cell Biochem 106 2009 867 877
33. G.A. Baltus, M.P. Kowalski, and H. Zhai Acetylation of sox2 induces its nuclear export in embryonic stem cells Stem Cells 27 2009 2175 2184
34. F. Medeiros, M.G. Muto, and Y. Lee The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome Am J Surg Pathol 30 2006 230 236 (Pubitemid 43740193)